ISRCTN ISRCTN47723701
DOI https://doi.org/10.1186/ISRCTN47723701
Secondary identifying numbers EPU-P31
Submission date
21/04/2010
Registration date
10/06/2010
Last edited
19/09/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Annemiek Vermeeren
Scientific

Universiteitssingel 40
Maastricht
6229ER
Netherlands

Email a.vermeeren@maastrichtuniversity.nl

Study information

Study design3 x 2 parallel group comparison trial
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Other
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEffects of insomnia and chronic use of hypnotics on driving performance: a parallel group comparison trial
Study objectivesThe present study aims to determine whether driving performance of chronic users of hypnotics and unmedicated insomnia patients differs from normal sleepers of the same age.
Ethics approval(s)Medical Ethics Committee of Maastricht University and University Hospital of Maastricht approved on the 20th June 2007 (ref: MEC 07-3-040)
Health condition(s) or problem(s) studiedInsomnia
Intervention3 x 2 parallel group design with three groups (chronic users, unmedicated insomnia patients, controls) and two within subject conditions (habituation and baseline).

Subjects were individually trained to perform the laboratory tests during two sessions of approximately 1.5 hours within 10 days before their first night. After training the subjects underwent two nights of sleep evaluation. The first night was a habituation and practice condition to familiarize subjects with the sleeping facilities and polysomnographic and test procedures. The second night was considered as the actual test condition.

A test condition started in the evening of Day 1, when the subjects arrived at the site at approximately 19:00 hours, and lasted until Day 2, when they were discharged at approximately 11:45 hours. On arrival at the sleeping facility, subjects rated their subjective feelings and subjective sleepiness. From 19:30 hours until 20:30 hours they performed the first session of laboratory tests, comprising the Word Learning Test immediate and first delayed recall, the Critical Tracking Task, the Divided Attention Task, the Psychomotor Vigilance Task, the Stop Signal Task, and the Digit Span forward and backward. Hereafter, electrodes for polysomnographic recording were attached.

Subjects retired to bed at 23:30 hours. Immediately preceding retiring, subjects in the chronic users group ingested their own prescribed hypnotic, whereas subjects in the unmedicated insomniacs group and controls did not ingest medication. Subjects were awakened at 07:30 hours and after arising a light standardized breakfast was served. At 08:00 hours subjects evaluated sleep quality and duration, and feelings of daytime sleepiness and alertness. Subsequently, they started the second session of laboratory tests, comprising the Word Learning Test second delayed recall and recognition, the Critical Tracking Task, the Divided Attention Task, the Psychomotor Vigilance Task, and the Digit Span forward and backward. At 9:00 hours blood samples were taken from the chronic users to determine serum concentrations of hypnotics before driving. Thereafter subjects were transported to the Highway Driving Test which they performed between 09:30 and 10:30 hours. Upon completion subjects rated the mental effort it took to perform this driving test, and subsequently they conducted the Car-Following Test. Upon completion of this test subjects returned to the testing facilities for removal of the electrodes and were discharged.
Intervention typeOther
Primary outcome measureStandard Deviation of Lateral Position (SDLP in cm) in the highway driving test
Secondary outcome measures1. Time to speed adaptation (in sec) and brake reaction time (in msec) in the car following test
2. Cognitive and psychomotor tests
Overall study start date01/06/2007
Completion date31/12/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants75 patients (25 in each group)
Total final enrolment63
Key inclusion criteria1. Healthy (except for patients complaints of insomnia)
2. Aged 55 year of older, either sex
3. Possession of a valid drivers license
4. Average annual driving experience of 3000 km per year over the last three years
Key exclusion criteria1. Abuse of alcohol, nicotine and caffeine
2. Use of medication that might affect driving performance (except hypnotics)
3. For patients:
3.1. Sleep-related breathing disorders
3.2. Circadian rhythm sleep disorders
3.3. Sleep related movement disorders
Date of first enrolment01/06/2007
Date of final enrolment31/12/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Universiteitssingel 40
Maastricht
6229ER
Netherlands

Sponsor information

Federal Highway Research Institute (Bundesanstalt für Straßenwesen) (Germany)
Research organisation

DRUID-Project
Brüderstrasse 53
Bergisch Gladbach
D-51427
Germany

Email druid@bast.de
Website http://www.bast.de
ROR logo "ROR" https://ror.org/046nzaj59

Funders

Funder type

Government

European Union (EU) (Belgium) - Sixth Framework Programme (FP6): Driving Under the Influence of Drug, Alcohol and Medicine (DRUID)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2014 19/09/2019 Yes No

Editorial Notes

19/09/2019: Publication reference and total final enrolment added.